Documentos relacionados

1. Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections.
2. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
3. Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3.
4. Metabolomic profile in patients with primary warm autoimmune haemolytic anaemia.
5. Paediatric-onset Evans syndrome: Breaking away from refractory immune thrombocytopenia.
6. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
7. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
8. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
9. The potential of metabolomics as a predictive guide for clinical management in autoimmunity against red blood cells.
10. Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.